Aminex Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.aminextx.com
Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Oral AMXT 1501 Dicaprate in Combination With IV DFMO
Phase 1
Terminated
- Conditions
- Advanced CancerDIPG Brain TumorOvary CancerMesotheliomas PleuralPapillary Thyroid CancerGastric CancerMesothelioma PeritoneumCancerNsclcCervical Cancer
- Interventions
- First Posted Date
- 2022-08-15
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Aminex Therapeutics, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05500508
- Locations
- 🇺🇸
Mayo Clinic - Arizona, Phoenix, Arizona, United States
🇺🇸Mayo Clinic - Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic - Minnesota, Rochester, Minnesota, United States
Oral AMXT 1501 Dicaprate in Combination With DFMO
Phase 1
Completed
- Conditions
- Advanced CancerCancerSolid CarcinomaSolid Tumor
- Interventions
- First Posted Date
- 2018-05-25
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- Aminex Therapeutics, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT03536728
- Locations
- 🇺🇸
Next Oncology - Austin Midtown, Austin, Texas, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Next Oncology - San Antonio, San Antonio, Texas, United States
Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers
Phase 1
Withdrawn
- Conditions
- ToleranceNeoplasmsMedication Toxicity
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- Aminex Therapeutics, Inc.
- Registration Number
- NCT03077477
- Locations
- 🇺🇸
IQVIA (formerly Quintiles IMS), Overland Park, Kansas, United States
News
No news found